RECEPTOR
Psychedelics will have a significant global impact by introducing novel and effective treatments for depression, addiction, PTSD, anxiety and other mental health disorders. Receptor invests in this new biotech ecosystem through early and mid stage drug discovery companies.
RECEPTOR
Industry:
Biopharma Neuroscience Venture Capital
Founded:
2021-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Google Apps For Business Squarespace Squarespace Hosted FullStory
Current Employees Featured
Zack Sherman General Partner @ Receptor
General Partner
2021-01-01
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-09-21 | MycroDose Therapeutics | Receptor investment in Seed Round - MycroDose Therapeutics | N/A |
2021-08-31 | Mindstate Design Labs | Receptor investment in Pre Seed Round - Mindstate Design Labs | 125 K USD |
2021-07-01 | Psilera Bioscience | Receptor investment in Seed Round - Psilera Bioscience | 2.5 M USD |